ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Rating) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 2,550,000 shares, a drop of 23.9% from the March 15th total of 3,350,000 shares. Based on an average daily volume of 544,700 shares, the days-to-cover ratio is […]
Wall Street analysts expect that CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Rating) will report earnings of ($0.10) per share for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for CASI Pharmaceuticals’ earnings. The highest EPS estimate is ($0.09) and the lowest is ($0.11). CASI Pharmaceuticals reported earnings per share of ($0.11) […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Rating) insider James Kihara sold 1,025 shares of the company’s stock in a transaction that occurred on Friday, April 8th. The stock was sold at an average price of $27.05, for a total value of $27,726.25. The transaction was disclosed in a legal filing with the Securities & Exchange […]
Applied Genetic Technologies (NASDAQ:AGTC – Get Rating) and TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Risk and Volatility Applied Genetic Technologies has a […]
CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Rating) was the target of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 88,300 shares, an increase of 4,805.6% from the March 15th total of 1,800 shares. Based on an average trading volume of 253,200 shares, the […]